| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.31▼ | 0.31▼ | 0.31▼ | 0.30▲ | 0.30▲ |
| MA10 | 0.31▼ | 0.32▼ | 0.31▼ | 0.29▲ | 0.32▼ |
| MA20 | 0.31▼ | 0.31▲ | 0.30▲ | 0.30▲ | 0.42▼ |
| MA50 | 0.32▼ | 0.30▲ | 0.29▲ | 0.32▼ | 0.62▼ |
| MA100 | 0.31▼ | 0.29▲ | 0.30▲ | 0.46▼ | 0.90▼ |
| MA200 | 0.30▲ | 0.31▼ | 0.32▼ | 0.61▼ | 1.94▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.001▼ | 0.001▲ | 0.005▲ | 0.003▲ |
| RSI | 38.679▼ | 52.630▲ | 56.203▲ | 50.609▲ | 35.401▼ |
| STOCH | 0.660▼ | 12.851▼ | 51.611 | 71.801 | 22.258 |
| WILL %R | -100.000▼ | -75.375▼ | -57.034 | -39.363 | -75.047▼ |
| CCI | -72.745 | -64.290 | 30.199 | 221.373▲ | -37.232 |
|
Monday, March 09, 2026 05:18 AM
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...
|
|
Tuesday, February 17, 2026 12:01 AM
In two non-GLP studies, CUE-401 was well tolerated with no adverse events observed Proof-of-concept studies reinforce promising preclinical profile and therapeutic potential of CUE-401 BOSTON, Mass., ...
|
|
Monday, February 16, 2026 11:00 PM
Detailed price information for Cue Biopharma Inc (CUE-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/03/26 | 0.3063 | 0.3409 | 0.3002 | 0.31 | 1,622,478 |
| 09/03/26 | 0.2883 | 0.3168 | 0.2866 | 0.301 | 613,640 |
| 06/03/26 | 0.3012 | 0.3047 | 0.2863 | 0.2998 | 601,305 |
| 05/03/26 | 0.3041 | 0.3059 | 0.2831 | 0.2878 | 235,049 |
| 04/03/26 | 0.2962 | 0.31 | 0.28 | 0.3023 | 256,289 |
| 03/03/26 | 0.2896 | 0.3025 | 0.2815 | 0.2962 | 350,804 |
| 02/03/26 | 0.271 | 0.30 | 0.271 | 0.2823 | 182,831 |
| 27/02/26 | 0.2842 | 0.2912 | 0.28 | 0.2801 | 169,421 |
| 26/02/26 | 0.2624 | 0.288 | 0.2624 | 0.2879 | 536,864 |
| 25/02/26 | 0.3029 | 0.3029 | 0.2734 | 0.2832 | 360,011 |
|
|
||||
|
|
||||
|
|